RLMD position history
The shares of Relmada Therapeutics (RLMD) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2023 Q3: 30,000 shares, $90K, 0.03% of portfolio, New
- 2023 Q4: 877,000 shares, $3.6M, 0.97% of portfolio, Add +2823.3%
- 2024 Q1: 1,518,000 shares, $7.1M, 1.6% of portfolio, Add +73.1%
- 2024 Q2: 600,000 shares, $1.8M, 0.41% of portfolio, Reduce −60.5%
- 2024 Q3: 480,000 shares, $1.6M, 0.26% of portfolio, Reduce −20.0%
- 2024 Q4: not held, Exit
- 2025 Q1: not held
- 2025 Q2: not held
- 2025 Q3: not held
- 2025 Q4: 1,870,000 shares, $9M, 1.2% of portfolio, New
- 2026 Q1: 935,000 shares, $6.5M, 0.86% of portfolio, Reduce −50.0%
- 2026 Q2: 935,000 shares, $6.5M, 0.59% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|